N-Methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity

Neurochemical Research

Volumn 34, Issue 3, 2009, Pages 490-498

  Nasr, Payman ^a   Carbery, Timothy ^b   Geddes, James W ^b  

^a KENT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

3 Nitropropionic acid; Excitotoxicity; Ifenprodil; Memantine; Metabolic impairment; MK 801; N Methyl d aspartate

Indexed keywords

3 NITROPROPIONIC ACID; DIZOCILPINE; IFENPRODIL; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEGENERATION; CONTROLLED STUDY; CORPUS STRIATUM; EXCITOTOXICITY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OSMOTIC MINIPUMP; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ADENOSINE DIPHOSPHATE; ANIMALS; CORPUS STRIATUM; DIZOCILPINE MALEATE; DRUG INTERACTIONS; MALE; MEMANTINE; MOTOR ACTIVITY; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; PIPERIDINES; POLY(ADP-RIBOSE) POLYMERASES; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TYROSINE;

EID: 59849105972     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9809-3     Document Type: Article

References (81)

1. MF Beal 1994 Neurochemistry and toxin models in Huntington's disease Curr Opin Neurol 7 542 547 10.1097/00019052-199412000-00012
2. S Palfi RJ Ferrante E Brouillet 1996 Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease J Neurosci 16 3019 3025
3. CV Borlongan TK Koutouzis PR Sanberg 1997 3-Nitropropionic acid animal model and Huntington's disease Neurosci Biobehav Rev 21 289 293 10.1016/S0149-7634(96)00027-9
4. MF Beal E Brouillet BG Jenkins 1993 Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J Neurosci 13 4181 4192
5. E Brouillet BG Jenkins BT Hyman 1993 Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid J Neurochem 60 356 359 10.1111/j.1471-4159.1993.tb05859.x
6. CV Borlongan TK Koutouzis TB Freeman 1997 Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model Brain Res Brain Res Protoc 1 253 257 10.1016/S1385-299X(96)00037-2
7. DH Gould MP Wilson DW Hamar 1985 Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants Toxicol Lett 27 83 89 10.1016/0378-4274(85)90123-7
8. Z Pang GH Umberger JW Geddes 1996 Neuronal loss and cytoskeletal disruption following intrahippocampal administration of the metabolic inhibitor malonate: lack of protection by MK-801 J Neurochem 66 474 484
9. E Brouillet MC Guyot V Mittoux 1998 Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat J Neurochem 70 794 805
10. A Novelli JA Reilly PG Lysko 1988 Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced Brain Res 451 205 212 10.1016/0006-8993(88)90765-2
11. RL Albin JT Greenamyre 1992 Alternative excitotoxic hypotheses Neurology 42 733 738
12. MF Beal BT Hyman W Koroshetz 1993 Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16 125 131 10.1016/0166-2236(93)90117-5
13. C Volbracht JV Van Beek C Zhu 2006 Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity Eur J NeuroSci 23 2611 2622 10.1111/j.1460-9568.2006.04787.x
14. L Nowak P Bregestovski P Ascher 1984 Magnesium gates glutamate-activated channels in mouse central neurons Nature 307 462 465 10.1038/307462a0
15. DW Choi 1985 Glutamate neurotoxicity in cortical cell culture is calcium dependent Neurosci Lett 58 293 297 10.1016/0304-3940(85)90069-2
16. SM Rothman JH Thurston RE Hauhart 1987 Delayed neurotoxicity of excitatory amino acids in vitro Neuroscience 22 471 480 10.1016/0306-4522(87) 90347-2
17. JW Olney 1990 Excitotoxicity: an overview Can Dis Wkly Rep 16 Suppl 1E 47 57 Discussion 57-58
18. MF Beal E Brouillet B Jenkins 1993 Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate J Neurochem 61 1147 1150 10.1111/j.1471-4159.1993.tb03633.x
19. JR Simpson O Isacson 1993 Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum Exp Neurol 121 57 64 10.1006/exnr.1993.1071
20. P Calabresi P Gubellini B Picconi 2001 Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine J Neurosci 21 5110 5120
21. 2+ entry during NMDA receptor activation FASEB 20 245 259 10.1096/fj.05-5085fje
22. KS Christopherson BJ Hillier WA Lim 1999 PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain J Biol Chem 274 27467 27473 10.1074/jbc.274.39.27467
23. R Sattler Z Xiong WY Lu 1999 Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein Science 284 1845 1848 10.1126/science.284.5421.1845
24. JS Beckman 1996 Oxidative damage and tyrosine nitration from peroxynitrite Chem Res Toxicol 9 836 844 10.1021/tx9501445
25. JS Beckman WH Koppenol 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 1424 1437
26. B Halliwell 1997 What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411 157 160 10.1016/S0014-5793(97)00469-9
27. JT Coyle P Puttfarcken 1993 Oxidative stress, glutamate, and neurodegenerative disorders Science 262 689 695 10.1126/science.7901908
28. H Ischiropoulos AB al-Mehdi 1995 Peroxynitrite-mediated oxidative protein modifications FEBS Lett 364 279 282 10.1016/0014-5793(95)00307-U
29. MF Beal RJ Ferrante SE Browne 1997 Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis Ann Neurol 42 644 654 10.1002/ana.410420416
30. BS Berlett B Friguet MB Yim 1996 Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: relevance to signal transduction Proc Natl Acad Sci USA 93 1776 1780 10.1073/pnas.93.5.1776
31. SK Kong MB Yim ER Stadtman 1996 Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2 (6-20) NH2 peptide Proc Natl Acad Sci USA 93 3377 3382 10.1073/pnas.93.8.3377
32. HC Ha SH Snyder 2000 Poly(ADP-ribose) polymerase-1 in the nervous system Neurobiol Dis 7 225 239 10.1006/nbdi.2000.0324
33. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 10.1038/227680a0
34. A Vezzani R Serafini MA Stasi 1989 Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats J Pharmacol Exp Ther 249 278 283
35. SA Lipton 1993 Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide Trends Neurosci 16 527 532 10.1016/0166-2236(93)90198-U
36. MJ Gallagher H Huang ER Grant 1997 The NR2B-specific interactions of polyamines and protons with the N-methyl-D-aspartate receptor J Biol Chem 272 24971 24979 10.1074/jbc.272.40.24971
37. DJ Laurie I Bartke R Schoepfer 1997 Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies Brain Res Mol Brain Res 51 23 32 10.1016/S0169-328X(97)00206-4
38. TW Butler JF Blake J Bordner 1998 (3R, 4S)-3-[4-(4-fluorophenyl)-4- hydroxypiperidin-1-yl]chroman-4, 7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S, 2S)-1-(4-hydroxyphenyl)-2-(4- hydroxy-4-phenylpiperidino)- 1-propanol J Med Chem 41 1172 1184 10.1021/jm9707986
39. DJ Goebel MS Poosch 1999 NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A Brain Res Mol Brain Res 69 164 170 10.1016/S0169-328X(99) 00100-X
40. Y Arai K Nakazato H Kinemuchi 1991 Inhibition of rat brain monoamine oxidase activity by cerebral anti-ischemic agent, ifenprodil Neuropharmacology 30 809 812 10.1016/0028-3908(91)90190-M
41. J Kurihara S Tamaoki H Kato 1993 Blockade of alpha 2-adrenoceptors protects the vagal baroreflex system from transient global cerebral ischemia in dogs Eur J Pharmacol 240 73 76 10.1016/0014-2999(93)90547-U
42. BA McCool DM Lovinger 1995 Ifenprodil inhibition of the 5-hydroxytryptamine3 receptor Neuropharmacology 34 621 629 10.1016/0028-3908(95) 00030-A
43. BL Chenard FS Menniti 1999 Antagonists selective for NMDA receptors containing the NR2B subunit Curr Pharm Des 5 381 404
44. L Ambrozi W Danielczyk 1988 Treatment of impaired cerebral function in psychogeriatric patients with memantine-results of a phase II double-blind study Pharmacopsychiatry 21 144 146
45. CG Parsons W Danysz G Quack 1999 Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-a review of preclinical data Neuropharmacology 38 735 767 10.1016/S0028-3908(99)00019-2
46. CG Parsons W Danysz G Quack 2000 Memantine and the amino-alkyl- cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists-in vitro characterisation Amino Acids 19 157 166 10.1007/s007260070044
47. GC Palmer 2001 Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies Curr Drug Targets 2 241 271 10.2174/1389450013348335
48. TE Finucane 2004 Memantine for patients with Alzheimer disease JAMA 291 1695 10.1001/jama.291.14.1695-a
49. CH Hirsch 2004 Memantine was better than placebo in Alzheimer disease already being treated with donepezil ACP J Club 141 38
50. PN Tariot M Farlow GT Grossberg 2004 Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial JAMA 291 317 324 10.1001/jama.291.3.317
51. TA Blanpied FA Boeckman E Aizenman 1997 Trapping channel block of NMDA-activated responses by amantadine and memantine J Neurophysiol 77 309 323
52. HS Chen SA Lipton 1997 Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism J Physiol 499 27 46
53. W Danysz CG Parsons J Kornhuber 1997 Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies Neurosci Biobehav Rev 21 455 468 10.1016/S0149-7634(96)00037-1
54. SR Bossi JR Simpson O Isacson 1993 Age dependence of striatal neuronal death caused by mitochondrial dysfunction NeuroReport 4 73 76 10.1097/00001756-199301000-00019
55. MC Guyot P Hantraye R Dolan 1997 Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid Neuroscience 79 45 56 10.1016/S0306-4522(96) 00602-1
56. ST Lee K Chu JE Park 2006 Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease Brain Res 1118 199 207 10.1016/j.brainres.2006.08.035
57. S Ouary N Bizat S Altairac 2000 Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implication for neuroprotection studies Neuroscience 97 521 530 10.1016/S0306-4522(00)00020-8
58. CE Teunissen M Markerink-van Ittersum C de Bruijn 2002 Evaluation of 3-nitrotyrosine as a marker for 3-nitropropionic acid-induced oxidative stress in Lewis and Wistar rats and strain-specific whole brain spheroid cultures Brain Res 931 5 20 10.1016/S0006-8993(01)03331-5
59. P Nasr HI Gursahani Z Pang 2003 Influence of cytosolic and mitochondrial Ca(2+), ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid Neurochem Int 43 89 99 10.1016/S0197-0186(02)00229-2
60. Z Pang JW Geddes 1997 Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis J Neurosci 17 3064 3073
61. GW Kim JC Copin M Kawase 2000 Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid J Cereb Blood Flow Metab 20 119 129 10.1097/00004647- 200001000-00016
62. DA Karanian AS Baude QB Brown 2006 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism Hippocampus 16 834 842 10.1002/hipo.20214
63. A Tozzi C Costa M Di Filippo 2007 Memantine reduces neuronal dysfunction triggered by in vitro ischemia and 3-nitropropionic acid Exp Neurol 207 218 226 10.1016/j.expneurol.2007.06.008
64. C Ikonomidou V Stefovska L Turski 2000 Neuronal death enhanced by N-methyl-D-aspartate antagonists Proc Natl Acad Sci USA 97 12885 12890 10.1073/pnas.220412197
65. T Frankiewicz CG Parsons 2004 Chronic memantine does not block 3-nitropropionic acid-delayed ischaemic tolerance in rat hippocampal slices ex vivo Neurotox Res 5 617 622
66. A Stefani Q Chen J Hernandez 1998 Physiological and molecular properties of AMPA/Kainate receptors expressed by striatal medium spiny neurons Dev Neurosci 20 242 252 10.1159/000017318
67. F Le Page V Schreiber C Dherin 2003 Poly(ADP-ribose) polymerase-1(PARP-1) is required in murine cell lines for base excision repair of oxidative DNA damage in absence of DNA polymerase beta J Biol Chem 278 18471 18477 10.1074/jbc.M212905200
68. SH Kaufmann 1989 Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note Cancer Res 49 5870 5878
69. YA Lazebnik SH Kaufmann S Desnoyers 1994 Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE Nature 371 346 347 10.1038/371346a0
70. GM Shah RG Shah GG Poirier 1996 Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells Biochem Biophys Res Commun 229 838 844 10.1006/bbrc.1996.1889
71. S Gobeil CC Boucher D Nadeau 2001 Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases Cell Death Differ 8 588 594 10.1038/sj.cdd.4400851
72. OA Andreassen RJ Ferrante DB Hughes 2000 Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant J Neurochem 75 847 852 10.1046/j.1471-4159.2000. 0750847.x
73. E McCracken D Dewar AJ Hunter 2001 White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat Brain Res 892 329 335 10.1016/S0006-8993(00)03266-2
74. JB Schulz RT Matthews MF Beal 1995 Role of nitric oxide in neurodegenerative diseases Curr Opin Neurol 8 480 486 10.1097/00019052- 199512000-00016
75. JB Schulz RT Matthews BG Jenkins 1995 Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo J Neurosci 15 8419 8429
76. MI Behrens J Koh LM Canzoniero 1995 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons NeuroReport 6 545 548 10.1097/00001756-199502000-00034
77. KW Muir KR Lees 1995 Clinical experience with excitatory amino acid antagonist drugs Stroke 26 503 513
78. SM Davis GW Albers HC Diener 1997 Termination of acute stroke studies involving selfotel treatment ASSIST steering committed Lancet 349 32 10.1016/S0140-6736(05)62166-6
79. B Ferger O Eberhardt P Teismann 1999 Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation J Neurochem 73 1329 1332 10.1046/j.1471-4159.1999. 0731329.x
80. JM Bekkers CF Stevens 1989 NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus Nature 341 230 233 10.1038/341230a0
81. Bloom FE (1990) In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon, New York, pp 244-268